These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A new probe for congenital nasolacrimal duct obstruction].
    Author: Xiao MY, Tong WL, Yao JP.
    Journal: Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):567-8. PubMed ID: 12658945.
    Abstract:
    OBJECTIVE: To investigate the therapeutic effect of a new probe for congenital nasolacrimal duct obstruction. METHODS: The probe was designed and manufactured by ourselves. We observed 158 cases (172 eyes) with congenital nasolacrimal duct obstruction and treated them with the probe 1-3 times. RESULTS: The mean period of postoperative follow-up was 17.8 (range 12-24 months) months. The success rate was 98.2%. Common complications included a slight blood-stained nasal discharge. CONCLUSION: Our newly designed and manufactured probe provides a new probe for congenital nasolacrimal duct obstruction. The probe is a safe, simple and effective treatment method for congenital nasolacrimal duct obstruction.
    [Abstract] [Full Text] [Related] [New Search]